Perceptions of lipodystrophy among PLHIV after 10 years of antiretroviral therapy in Senegal;Perceptions des lipodystrophies chez les PVVIH à 10 ans de traitement antirétroviral au Sénégal

Bulletin de la Societe de Pathologie Exotique

Volumn 107, Issue 4, 2014, Pages 246-251

  Desclaux, A ^a,b   Boye, S ^b,c  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^b Centre Regional de Recherche et de Formation sur la Prise en chargeclinique   (Senegal)

^c UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

Author keywords

Adverse Effects; ANRS Cohort 1215; ART; Dakar; HIV; Lipodystrophy; Perceptions; PLHIV; Qualitative Study; Senegal; Sub Saharan Africa

Indexed keywords

ADULT; COMPLICATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LIPODYSTROPHY; MALE; MIDDLE AGED; PERCEPTION; PSYCHOLOGY; SELF CONCEPT; SENEGAL; SOCIAL STIGMA;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LIPODYSTROPHY; MALE; MIDDLE AGED; PERCEPTION; SELF CONCEPT; SENEGAL; SOCIAL STIGMA;

EID: 84919842030     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13149-014-0357-6     Document Type: Article

References (19)

1. Alcano MC (2009) Living and working in spite of antiretroviral therapies: strength in chronicity. Anthropology & Medicine 16(2):119–130
2. Behrens GM (2008) Treatment options for lipodystrophy in HIVpositive patients. Expert Opin Pharmacother 9(1):39–52
3. Brewis AA, Wutich A, Falletta-Cowden A, Rodriguez-Soto I (2011) Body Norms and Fat Stigma in Global Perspective. Current Anthropology 52(2): 269–276
4. Carr A (2003) HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. AIDS 17(S1):S141–S148
5. Diouf JL (2003) Dictionnaire wolof-français et français-wolof, Paris, Karthala
6. Dube NM, Summers R, Tint KS, Mayayise G (2012) A pharmacovigilance study of adults on highly active antiretroviral therapy, South Africa: 2007–2011. Pan Afr Med J 11:39
7. Ezekiel MJ, Talle A, Juma JM, Klepp KI (2009) “When in the body, it makes you look fat and HIV negative”: The constitution of antiretroviral therapy in local discourse among youth in Kahe, Tanzania. Soc Sci Med 68(5):957–964
8. Hurley E, Coutsoudis A, Giddy J, et al (2011) Weight evolution and perceptions of adults living with HIV following initiation of antiretroviral therapy in a South African urban setting. S Afr Med J 101(9):645–650
9. Keusch GT, Wilentz J, Kleinman A (2006) Stigma and global health: developing a research agenda. Lancet 367(9509):52527
10. Makinson A, Moing VL, Kouanfack C, et al (2008) Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings. Expert Opin Drug Saf 7(3):283–293
11. Mercier S, Gueye NF, Cournil A, et al (2009) Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study. J Acquir Immune Defic Syndr 51(2): 224–230
12. Mykén N, Sundbeck B, Mpumilwa G, Andersson R (2009) Developing countries need better antiretroviral drugs. J Int Assoc Physicians AIDS Care (Chic) 8(1): 23–24
13. Nam SL, Fielding K, Avalos A, et al (2008) The relationship of acceptance or denial of HIV-status to antiretroviral adherence among adult HIV patients in urban Botswana. Soc Sci Med 67(2):301–310
14. Peretti-Watel P, Spire B, Pierret J, et al (2006) Management of HIV-related stigma and adherence to HAART: Evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003). AIDS Care 18(3): 254–261
15. Persson A, Newman C (2006) Potency and vulnerability: Troubled ‘selves’ in the context of antiretroviral therapy. Soc Sci Med 63(6):1586–1596
16. Schumaker LL, Bond VA (2008) Antiretroviral therapy in Zambia: Colours, ‘spoiling’, ‘talk’ and the meaning of antiretrovirals. Soc Sci Med 67(12):2126–2134
17. Taverne B, Desclaux A, Sow PS et aI (2012) Evaluation de l’impact bio-clinique et social, individuel et collectif, du traitement ARV chez des patients VIH-1 pris en charge depuis 10 ans dans le cadre de l’ISAARV — Cohorte ANRS 1215. IRD/CRCF. Consulted June 21, 2013 http://hal.ird.fr/ird-00718213
18. Womack J (2009) HIV-Related Lipodystrophy in Africa and Asia. AIDS Read 19(4):131–139
19. Zannou DM, Denoeud L, Lacombe K, et al (2009) Incidence of lipodystrophy and metabolic disorders in patients starting nonnucleoside reverse transcriptase inhibitors in Benin. Antivir Ther 14(3):371–380